Literature DB >> 24046034

Total hip arthroplasty revision in elderly patients.

Elena Gasbarra1, Fabio Luigi Perrone, Monica Celi, Cecilia Rao, Maurizio Feola, Nicola Cuozzo, Umberto Tarantino.   

Abstract

In the last years, the number of total hip arthroplasty is increased both in young patients and elderly with a poor bone quality due to extension of surgical indications. According to this trend, also revision surgery showed a growth of its number, especially in elderly patients, because of implant loosening, failed osseointegration of prosthetic components, errors in biomechanical restoration and infections. The aim of this study is to analyze life quality improvement through evaluation of articular functionality and postoperative pain, and to examine osseointegration of implant components with periprosthetic bone. During total hip arthroplasty revision, the orthopedic surgeon often has to face complex cases, especially in elderly patients with a preexisting status of poor bone quality and sarcopenia. In these cases, a correct planning and a surgical procedure well-executed are able to ensure a good outcome that led to pain relief and functional recovery. Furthermore anti-osteoporotic therapy surely represents a useful resource both in primary total hip arthroplasty and in revisions, mainly for elderly patients with a poor bone quality.

Entities:  

Mesh:

Year:  2013        PMID: 24046034     DOI: 10.1007/s40520-013-0109-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

1.  Machine learning-based identification of hip arthroplasty designs.

Authors:  Yang-Jae Kang; Jun-Il Yoo; Yong-Han Cha; Chan H Park; Jung-Taek Kim
Journal:  J Orthop Translat       Date:  2019-12-20       Impact factor: 5.191

2.  What Are Risk Factors for Infection after Primary or Revision Total Joint Arthroplasty in Patients Older Than 80 Years?

Authors:  Nipun Sodhi; Hiba K Anis; Rushabh M Vakharia; Alexander J Acuña; Peter A Gold; Luke J Garbarino; Bilal M Mahmood; Nicholas R Arnold; Joseph O Ehiorobo; Eric L Grossman; Michael A Mont; Martin W Roche
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.